Preterm Premature Rupture of Membranes Clinical Trial
Official title:
Is Outpatient Management of PPROM Equivalent to Hospital Management
This study is to compare the maternal and neonatal outcomes in the patients with PPROM who are managed at home versus those managed at hospital, half the patients will be managed at home and the other half will be managed inpatient.
Status | Recruiting |
Enrollment | 560 |
Est. completion date | July 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: 1. PPROM with gestational age between 27 to 34 weeks 2. Cephalic presentation 3. Clear amniotic fluid 4. Oral temperature > 38 C 5. Near distance from the hospital (the patient can reach hospital within one hour ) 6. Home environment safe and amenable to rest , availability of family support such as a sister or mother who will help the patient at home . 7. Maternal and fetal condition remain stable after hospitalization for 72 hours Exclusion Criteria: 1. Patient with equivocal diagnosis of rupture of membranes 2. advanced labor 3. intrauterine infection 4. vaginal bleeding or 5. non reassuring fetal heart rate. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Egypt | Ain Shams Maternity hospital | Cairo | Abbasya |
Lead Sponsor | Collaborator |
---|---|
Ain Shams Maternity Hospital | Ain Shams University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | rate occurence of Neonatal sepsis | proven neonatal infection with positive blood culture within 48 hours after birth, or culture proven neonatal pneumonia or meningitis | 48 hours after delivery | Yes |
Secondary | rate of occurence of Maternal morbidity | including chorioamnionitis , endometritis , septicaemia, admission to intensive care unit, organ failure, major postpartum hemorrhage | 48 hours after delivery | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01431248 -
PPROM Erythromycin Versus Azithromycin
|
N/A | |
Active, not recruiting |
NCT04588220 -
Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
|
||
Completed |
NCT02314728 -
Cervical Ripening in Premature Rupture of Membranes
|
N/A | |
Not yet recruiting |
NCT01152528 -
Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery
|
Phase 3 | |
Completed |
NCT02702297 -
Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
|
||
Not yet recruiting |
NCT02635451 -
The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes
|
N/A | |
Completed |
NCT01266928 -
Does Vitamins C and E Supplementation of After Preterm Rupture of Membranes Prolong the Duration of Latency? A Prospective Randomized Controlled Study
|
Phase 3 | |
Active, not recruiting |
NCT04532021 -
Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM
|
||
Recruiting |
NCT01584323 -
Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes
|
N/A | |
Recruiting |
NCT00466128 -
Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)
|
Phase 2 | |
Terminated |
NCT00463736 -
Magnesium Sulfate Versus Placebo for Tocolysis in PPROM
|
N/A |